Other News

Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D.

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD), maker of the Impella heart pump, announced today it has appointed Charles (Chuck) Simonton, M.D., as vice president and chief medical officer. Dr. Simonton is renowned for his leadership in product development and large-scale clinical trials. He was most recently at Abbott Vascular where he served as chief medical officer […]

Puzzle Medical Devices Inc. announces the closing of a first financing round; provides update on its minimally invasive transcatheter heart pump

MONTREAL, June 15, 2020 /PRNewswire/ – Puzzle Medical Devices Inc., (www.puzzlemed.com) announces the closure of its first convertible debenture financing round led by Canadian entrepreneur Pascal Labrecque. Other participants include a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe. This investment follows the successful completion of Puzzle Medical’s first preclinical studies […]

Heartbeat Health and The American College of Cardiology Join to Revolutionize Cardiology With Breakthrough Virtual Care

Using wearables and devices, physicians can incorporate clinical data into telehealth visits to offer complete remote health management. NEW YORK, June 15, 2020 /PRNewswire/ — The American College of Cardiology (ACC) and Heartbeat Health, the first telemedicine and virtual care platform built by cardiologists for cardiologists, are joining forces to transform telehealth into […]

Medtronic Micra™ AV Receives CE Mark

World’s Smallest Pacemaker Can Now Treat Patients with AV Block, Allowing More Potential Candidates for Leadless Pacing DUBLIN, June 15, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for Micra™ AV Transcatheter Pacing System (TPS), the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra […]

Endonovo Therapeutics Announces First Quarter Fiscal 2020 Financial Results

Los Angeles, CA, June 15, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), today announces financial and operating results for the first quarter ended March 31, 2020. Company improved financial and operating results are reflected in every major financial category, as compared to first quarter […]

Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market

Vancouver, BC, June 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE –Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 3,883,036 common shares at a purchase price of […]

LivaNova Announces Proposed Private Offering of $250 Million of Cash Exchangeable Senior Notes

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) today announced its intention to offer $250 million aggregate principal amount of cash exchangeable senior notes due 2025 through its wholly owned U.S. subsidiary, LivaNova USA, Inc., in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, […]

Radcliffe Cardiology Announces New Educational Hub, Arrhythmia Academy

LONDON, June 10, 2020 /PRNewswire/ — An exciting new digital platform – ‘Arrhythmia Academy’ launches today – dedicated to arrhythmia and electrophysiology specialists. This new scientific content hub is led by Editor-in-Chief Prof Angelo Auricchio, MD, PhD, (Lugano, Switzerland) and is supported by a stellar, international editorial board. In association with leading Cardiovascular content provider Radcliffe […]

Verve Therapeutics Raises $63 million in Series A2 Financing to Advance Gene-Editing Therapies for Heart Disease

Proceeds Will Be Used to Progress Lead Program to Phase 1 Clinical Trials and Expand Pipeline Programs CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a next-generation cardiovascular company developing therapies that safely edit the adult human genome to permanently reduce a person’s risk of coronary heart disease, today announced it has raised $63 […]

Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk

Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson PARIS–(BUSINESS WIRE)–Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today […]